The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Mechanized Silica Nanoparticles: A New Frontier in Theranostic Nanomedicine
Open accessAbstract
Medicine can benefit significantly from advances in nanotechnology because nanoscale assemblies promise to improve on previously established therapeutic and diagnostic regimes. Over the past decade, the use of delivery platforms has attracted attention as researchers shift their focus toward new ways to deliver therapeutic and/or diagnostic agents and away from the development of new drug candidates. Metaphorically, the use of delivery platforms in medicine can be viewed as the "bow-and-arrow" approach, where the drugs are the arrows and the delivery vehicles are the bows. Even if one possesses the best arrows that money can buy, they will not be useful if one does not have the appropriate bow to deliver the arrows to their intended location. Currently, many strategies exist for the delivery of bioactive agents within living tissue. Polymers, dendrimers, micelles, vesicles, and nanoparticles have all been investigated for their use as possible delivery vehicles. With the growth of nanomedicine, one can envisage the possibility of fabricating a theranostic vector that could release powerful therapeutics and diagnostic markers simultaneously and selectively to diseased tissue. In our design of more robust theranostic delivery systems, we have focused our attention on using mesoporous silica nanoparticles (SNPs). The payload "cargo" molecules can be stored within this robust domain, which is stable to a wide range of chemical conditions. This stability allows SNPs to be functionalized with stimulus-responsive mechanically interlocked molecules (MIMs) in the shape of bistable rotaxanes and psuedorotaxanes to yield mechanized silica nanoparticles (MSNPs). In this Account, we chronicle the evolution of various MSNPs, which came about as a result of our decade-long collaboration, and discuss advances in the synthesis of novel hybrid SNPs and the various MIMs which have been attached to their surfaces. These MIMs can be designed in such a way that they either change shape or shed off some of their parts in response to a specific stimulus, such as changes in redox potential, alterations in pH, irradiation with light, or the application of an oscillating magnetic field, allowing a theranostic payload to be released from the nanopores to a precise location at the appropiate time. We have also shown that these integrated systems can operate not only within cells, but also in live animals in response to pre-existing biological triggers. Recognizing that the theranostics of the future could offer a fresh approach to the treatment of degenerative diseases including cancer, we aim to start moving out of the chemical domain and into the biological one. Some MSNPs are already being tested in biological systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism
Kresge, C. T., Leonowicz, M. E., Roth, W. J., Vartuli, J. C., & Beck, J. S. (1992) · Nature · doi:10.1038/359710a0 · Cited by 16,275
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery
Liong, M., Lu, J., Kovochich, M., Xia, T., Ruehm, S. G., Nel, A. E., Tamanoi, F., & Zink, J. I. (2008) · ACS Nano · doi:10.1021/nn800072t · Cited by 1,929
Self-citationTrewyn, B. G., Slowing, I. I., Giri, S., Chen, H.-T., & Lin, V. S.-Y. (2007) · Accounts of Chemical Research · doi:10.1021/ar600032u · Cited by 1,123
Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica
Mal, N. K., Fujiwara, M., & Tanaka, Y. (2003) · Nature · doi:10.1038/nature01362 · Cited by 1,094
Lu, J., Liong, M., Li, Z., Zink, J. I., & Tamanoi, F. (2010) · Small · doi:10.1002/smll.201000538 · Cited by 1,074
Self-citationMesoporous Silica Nanoparticles as a Delivery System for Hydrophobic Anticancer Drugs
Lu, J., Liong, M., Zink, J. I., & Tamanoi, F. (2007) · Small · doi:10.1002/smll.200700005 · Cited by 1,012
Self-citationMesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery
Vivero‐Escoto, J. L., Slowing, I. I., Trewyn, B. G., & Lin, V. S. ‐. (2010) · Small · doi:10.1002/smll.200901789 · Cited by 998
Xia, T., Kovochich, M., Liong, M., Meng, H., Kabehie, S., George, S., Zink, J. I., & Nel, A. E. (2009) · ACS Nano · doi:10.1021/nn900918w · Cited by 933
Self-citationMeng, H., Liong, M., Xia, T., Li, Z., Ji, Z., Zink, J. I., & Nel, A. E. (2010) · ACS Nano · doi:10.1021/nn100690m · Cited by 902
Self-citation
Cited by
Metal–Organic Frameworks in Biomedicine
Horcajada, P., Gref, R., Baati, T., Allan, P. K., Maurin, G., Couvreur, P., Férey, G., Morris, R. E., & Serre, C. (2012) · Chemical Reviews · doi:10.1021/cr200256v · Cited by 4,168
Cucurbituril-Based Molecular Recognition
Barrow, S. J., Kasera, S., Rowland, M. J., del Barrio, J., & Scherman, O. A. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00341 · Cited by 1,898
The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy
Doane, T. L., & Burda, C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15260f · Cited by 1,098
Mesoporous Silica Nanoparticle Nanocarriers: Biofunctionality and Biocompatibility
Tarn, D., Ashley, C. E., Xue, M., Carnes, E. C., Zink, J. I., & Brinker, C. J. (2013) · Accounts of Chemical Research · doi:10.1021/ar3000986 · Cited by 949
Self-citationMesoporous Silica Nanoparticles for Drug Delivery
Manzano, M., & Vallet‐Regí, M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201902634 · Cited by 939
Zdarta, J., Meyer, A., Jesionowski, T., & Pinelo, M. (2018) · Catalysts · doi:10.3390/catal8020092 · Cited by 934
Qian, X., Zheng, Y., & Chen, Y. (2016) · Advanced Materials · doi:10.1002/adma.201602012 · Cited by 882
Croissant, J. G., Fatieiev, Y., & Khashab, N. M. (2017) · Advanced Materials · doi:10.1002/adma.201604634 · Cited by 782
Zhou, J., Yu, G., & Huang, F. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00898d · Cited by 677
Croissant, J. G., Fatieiev, Y., Almalik, A., & Khashab, N. M. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700831 · Cited by 594
Emami, F. S., Puddu, V., Berry, R. J., Varshney, V., Patwardhan, S. V., Perry, C. C., & Heinz, H. (2014) · Chemistry of Materials · doi:10.1021/cm500365c · Cited by 567
Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
Vallet-Regí, M., Schüth, F., Lozano, D., Colilla, M., & Manzano, M. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00659b · Cited by 507
Tonga, G. Y., Jeong, Y., Duncan, B., Mizuhara, T., Mout, R., Das, R., Kim, S. T., Yeh, Y.-C., Yan, B., Hou, S., et al. (2015) · Nature Chemistry · doi:10.1038/nchem.2284 · Cited by 497
Gated Materials for On-Command Release of Guest Molecules
Aznar, E., Oroval, M., Pascual, L., Murguía, J. R., Martínez-Máñez, R., & Sancenón, F. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00456 · Cited by 488
DNA Switches: From Principles to Applications
Wang, F., Liu, X., & Willner, I. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201404652 · Cited by 467
Ma, D., Hettiarachchi, G., Nguyen, D., Zhang, B., Wittenberg, J. B., Zavalij, P. Y., Briken, V., & Isaacs, L. (2012) · Nature Chemistry · doi:10.1038/nchem.1326 · Cited by 451
Choi, K. Y., Liu, G., Lee, S., & Chen, X. (2012) · Nanoscale · doi:10.1039/c1nr11277e · Cited by 437
Sol-Gel processing of silica nanoparticles and their applications
Singh, L. P., Bhattacharyya, S. K., Kumar, R., Mishra, G., Sharma, U., Singh, G., & Ahalawat, S. (2014) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2014.10.007 · Cited by 428
The surface chemistry of metal–organic frameworks
McGuire, C. V., & Forgan, R. S. (2015) · Chemical Communications · doi:10.1039/c4cc04458d · Cited by 396
Chen, Y., Meng, Q., Wu, M., Wang, S., Xu, P., Chen, H., Li, Y., Zhang, L., Wang, L., & Shi, J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja508721y · Cited by 374
Delivery of drugs, proteins, and nucleic acids using inorganic nanoparticles
Luther, D. C., Huang, R., Jeon, T., Zhang, X., Lee, Y.-W., Nagaraj, H., & Rotello, V. M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.020 · Cited by 364
Chen, Y., & Shi, J. (2016) · Advanced Materials · doi:10.1002/adma.201505147 · Cited by 356
Yu, X., Li, A., Zhao, C., Yang, K., Chen, X., & Li, W. (2017) · ACS Nano · doi:10.1021/acsnano.7b00476 · Cited by 339
Multifunctional Mesoporous Silica Nanoparticles for Cancer‐Targeted and Controlled Drug Delivery
Zhang, Q., Liu, F., Nguyen, K. T., Ma, X., Wang, X., Xing, B., & Zhao, Y. (2012) · Advanced Functional Materials · doi:10.1002/adfm.201201316 · Cited by 324
Self-citationFunctional Mesoporous Silica Nanoparticles for Photothermal‐Controlled Drug Delivery In Vivo
Yan, H., Teh, C., Sreejith, S., Zhu, L., Kwok, A., Fang, W., Ma, X., Nguyen, K. T., Korzh, V., & Zhao, Y. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203993 · Cited by 317
Self-citationLing, K., Men, F., Wang, W.-C., Zhou, Y.-Q., Zhang, H.-W., & Ye, D.-W. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01153 · Cited by 313
Liu, J., Luo, Z., Zhang, J., Luo, T., Zhou, J., Zhao, X., & Cai, K. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.008 · Cited by 294
Arcos, D., & Vallet-Regí, M. (2013) · Acta Materialia · doi:10.1016/j.actamat.2012.10.039 · Cited by 282
Zhang, Q., Wang, X., Li, P., Nguyen, K. T., Wang, X., Luo, Z., Zhang, H., Tan, N. S., & Zhao, Y. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201302988 · Cited by 276
Self-citationGong, H., Dong, Z., Liu, Y., Yin, S., Cheng, L., Xi, W., Xiang, J., Liu, K., Li, Y., & Liu, Z. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201401451 · Cited by 274
Min, K. H., Min, H. S., Lee, H. J., Park, D. J., Yhee, J. Y., Kim, K., Kwon, I. C., Jeong, S. Y., Silvestre, O. F., Chen, X., et al. (2015) · ACS Nano · doi:10.1021/nn506210a · Cited by 265
Nanomachines and Other Caps on Mesoporous Silica Nanoparticles for Drug Delivery
Chen, W., Glackin, C. A., Horwitz, M. A., & Zink, J. I. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00116 · Cited by 264
Self-citationStimuli-Responsive Drug-Delivery Systems Based on Supramolecular Nanovalves
Li, Z., Song, N., & Yang, Y.-W. (2019) · Matter · doi:10.1016/j.matt.2019.05.019 · Cited by 256
Mekaru, H., Lu, J., & Tamanoi, F. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.009 · Cited by 256
AbouAitah, K., Swiderska-Sroda, A., Farghali, A. A., Wojnarowicz, J., Stefanek, A., Gierlotka, S., Opalinska, A., Allayeh, A. K., Ciach, T., & Lojkowski, W. (2018) · Oncotarget · doi:10.18632/oncotarget.25470 · Cited by 83
Development of Mesoporous Silica Nanomaterials As a Vehicle for Anticancer Drug Delivery
Yanes, R. E., & Tamanoi, F. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.9 · Cited by 68
Metadata
- Authors
- Ambrogio, M. W., Thomas, C. R., Zhao, Y.-L., Zink, J. I., & Stoddart, J. F.
- Venue
- Accounts of Chemical Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2011-06-15
- Volume
- 44
- Issue
- 10
- Pages
- 903-913
- ISSN
- 0001-4842 (ISSN-L)
- 1520-4898
- OpenAlex
- W2055180419
- Cited by
- 604
- References
- 50
- FWCI
- 26.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.